Researcher profile · Semantic Scholar

K. Putzker

h-index: 7
Works: 17
Citations: 423

Most-cited papers

Drug-perturbation-based stratification of blood cancer
Sascha Dietrich, M. Oleś, Junyan Lu, L. Sellner +47 more
2017Journal of Clinical Investigation143 citations Open access
Semantic Scholar
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.
S. Dieter, Christine Siegl, Paula L Codo, Mario Huerta +28 more
2021Cell Reports81 citations Open access
Semantic Scholar
Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity.
S. Daum, V. Chekhun, I. Todor, N. Lukianova +11 more
2015Journal of Medicinal Chemistry69 citations Open access
Semantic Scholar
5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion
Madhuri Bhuvanagiri, J. Lewis, K. Putzker, Jonas P. Becker +9 more
2014EMBO Molecular Medicine60 citations Open access
Semantic Scholar
Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response
Stefanie Höfer, Larissa Frasch, Sarah Brajkovic, K. Putzker +11 more
2024bioRxiv20 citations Open access
Semantic Scholar
Real‐world evidence for preventive effects of statins on cancer incidence: A trans‐Atlantic analysis
B. Gohlke, Fabian Zincke, Andreas Eckert, D. Kobelt +12 more
2021medRxiv20 citations Open access
Semantic Scholar
Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics
Chien-Yun Lee, M. The, Chen Meng, Florian P. Bayer +9 more
2023Molecular Systems Biology14 citations Open access
Semantic Scholar
Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis.
Shi-Xian Yan, P. Schöpe, Joe Lewis, K. Putzker +13 more
2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie6 citations Open access
Semantic Scholar
Synthesis of Novel Laurenditerpenol Analogues and their Evaluation as HIF-1 Activation Inhibitors
Nikolaos Athinaios, A. Kazantzis, K. Putzker, J. Lewis +1 more
20093 citations
Semantic Scholar
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening.
Marcel F Pohly, K. Putzker, S. Scheinost, Lena Ben Taarit +21 more
2025Blood2 citations
Semantic Scholar
A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compounds
Thijs C. J. Verheul, N. Gillemans, K. Putzker, Rezin Majied +12 more
2024HemaSphere2 citations Open access
Semantic Scholar
Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling
Alina Batzilla, Jun-Yan Lu, Jarno Kivioja, K. Putzker +3 more
2022bioRxiv2 citations Open access
Semantic Scholar
Synthesis of Novel Laurenditerpenol Analogues and Their Evaluation as HIF-1 Activation Inhibitors.
Nikolaos Athinaios, A. Kazantzis, K. Putzker, J. Lewis +1 more
20091 citations
Semantic Scholar
SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING
K. Hofer, S. Scheinost, L. Ben‐Taarit, J. Hüllein +17 more
2025Hematological Oncology0 citations
Semantic Scholar
Novel High-Throughput Screen Identified S100A4 Inhibitors for Anti-Metastatic Therapy
P. Schöpe, Nina Heisterkamp, Devin Schütz, G. Mastrobuoni +7 more
2025International Journal on Biological Sciences0 citations Open access
Semantic Scholar
Abstract 2471: Novel Tetrazolo-pyridazine based MACC1 inhibitors are promising for anti-metastatic therapy
Shi-Xian Yan, P. Schöpe, J. Lewis, K. Putzker +12 more
2023Cancer Research0 citations
Semantic Scholar
Abstract A039: Novel tetrazolo-pyridazine based MACC1 transcriptional inhibitors as promising anti-metastatic therapy
P. Schöpe, Shi-Xian Yan, D. Kobelt, J. Lewis +13 more
2023Cancer Research0 citations
Semantic Scholar

W. Walther

×4

P. Schöpe×4

L. Sellner×3

T. Walther×3

B. Kuster×3

Shi-Xian Yan×3

E. Specker×3

J. V. von Kries×3